p. 3878 - 3879
(2007/10/03)p. 1581 - 1588
(2007/10/03)p. 3931 - 3942
(2007/10/03)p. 606 - 615
(2007/10/03)p. 1061 - 1064
(2007/10/03)p. 1391 - 1394
(2007/10/03)p. 589 - 594
(2007/10/03)p. 8287 - 8290
(2007/10/03)p. 757 - 759
(2007/10/02)p. 408 - 414
(2007/10/02)p. 1437 - 1440
(2007/10/02)p. 2469 - 2472
(2007/10/02)(2Z,4E)-3-methyl-5-(2',6',6'-trimethylcyclohex-1'-en-1'-yl)-2,4-pentadienoic acid
N-benzyl-N-methoxy-3-(2,6,6-trimethyl-cyclohex-1-enyl)-acrylamide
(E)-β-ionone
(E)-5-(2,6,6-Trimethyl-cyclohex-1-enyl)-pent-4-en-2-ynoic acid ethyl ester
2‐iodo‐1,3,3‐trimethylcyclohex‐1‐ene
9Z,11E,13Z-12-carboxyretinoic acid
N,N-dimethyl-glycine-[3-methyl-5t-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2c,4-dienylidenehydrazide]
3-methyl-5t-(2,6,6-trimethyl-cyclohex-1-enyl)-penta-2c,4-dienal semicarbazone
(+/-)-7-hydroxy-3.7-dimethyl-1t-(2.2.6-trimethyl-cyclohexen-(6)-yl)-nonatrien-(1.3t.5t)-oic acid-(9)-ethyl ester
9,13-di-cis-retinoic acid